Andere talen Evolent Health, Inc.

Aandelen

EVH

US30050B1017

Beurs gesloten - Nyse Andere beurzen 22:00:02 23-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
22,89 ^USD	-1,63%		-2,80%	-30,70%

14/05	EVOLENT HEALTH, INC. : Truist Securities vindt het aandeel niet inspirerend	ZM
10/05	EVOLENT HEALTH, INC. : Een koopadvies van UBS	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Evolent Health: Q1 Earnings Snapshot	09/05
Evolent Health Q1 Adjusted Earnings, Revenue Rise; Q2 Revenue Guidance Set, 2024 Revenue Outlook Increased	09/05
Earnings Flash (EVH) EVOLENT HEALTH Posts Q1 EPS $0.34, vs. Street Est of $0.30	09/05
Earnings Flash (EVH) EVOLENT HEALTH Posts Q1 Revenue $639.7M, vs. Street Est of $598.9M	09/05
Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.	09/05
Evolent Health, Inc. and Careology Form Strategic Care Navigation Partnership to Enhance Cancer Care in the U.S	09/05
Evolent Announces First Quarter 2024 Results	09/05
Evolent Health, Inc. Provides Earnings Guidance for the Second Quarter Ending June 30, 2024 and Raises Earnings Guidance for the Full Year Full Year Ending December 31, 2024	09/05
Evolent Health : 2024 Notice of Meeting and Proxy Statement	26/04
Evolent Health : 2024 Proxy Card	26/04
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024	18/04
Evolent Health Q4 Adjusted Income, Revenue Rise; Q1, 2024 Revenue Guidance Set; Shares Jump After Hours	22/02
Evolent Health: Q4 Earnings Snapshot	22/02
Earnings Flash (EVH) EVOLENT HEALTH Reports Q4 EPS $0.23, vs. Street Est of $0.15	22/02
Earnings Flash (EVH) EVOLENT HEALTH Posts Q4 Revenue $556.1M, vs. Street Est of $542.9M	22/02
Evolent Announces Fourth Quarter and Full Year 2023 Results	22/02
Evolent Health, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year Ending December 31, 2024	22/02
Evolent Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	22/02
Evolent Adds Russell Glass, Headspace CEO, to Board of Directors	14/02
Evolent Health, Inc. Announces Board Changes	14/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Evolent Health, Inc.

Aandelen

EVH

US30050B1017

Andere talen

Filters